BlackRock Institutional Trust’s MGC Diagnostics Corporation MGCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$821K Hold
104,079
﹤0.01% 3343
2016
Q3
$729K Hold
104,079
﹤0.01% 3391
2016
Q2
$679K Hold
104,079
﹤0.01% 3430
2016
Q1
$638K Hold
104,079
﹤0.01% 3399
2015
Q4
$687K Hold
104,079
﹤0.01% 3424
2015
Q3
$687K Hold
104,079
﹤0.01% 3433
2015
Q2
$593K Hold
104,079
﹤0.01% 3475
2015
Q1
$751K Sell
104,079
-11,529
-10% -$80.3K ﹤0.01% 3418
2014
Q4
$740K Sell
115,608
-1,003
-0.9% -$6.54K ﹤0.01% 3419
2014
Q3
$764K Sell
116,611
-3,035
-3% -$23.5K ﹤0.01% 3401
2014
Q2
$993K Buy
119,646
+400
+0.3% +$3.96K ﹤0.01% 3437
2014
Q1
$1.36M Buy
119,246
+10,269
+9% +$116K ﹤0.01% 3312
2013
Q4
$1.38M Buy
108,977
+23,132
+27% +$283K ﹤0.01% 3295
2013
Q3
$940K Buy
85,845
+1,099
+1% +$9.88K ﹤0.01% 3374
2013
Q2
$708K Buy
+84,746
New +$616K ﹤0.01% 3412

Other funds holding MGCD

BlackRock Institutional Trust's MGCD Position: Q4 2016 in Review

BlackRock Institutional Trust held its MGC Diagnostics Corporation (MGCD) position steady in Q4 2016 at 104,079 shares worth $821K. The position accounts for ﹤0.01% of the portfolio, ranked #3343.

BlackRock Institutional Trust first reported a position in MGCD in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.38M in Q4 2013. 15 funds tracked by Wall St. Rank hold MGCD as of Q4 2016.

  • BlackRock Institutional Trust held 104,079 shares of MGC Diagnostics Corporation worth $821K as of Q4 2016.
  • BlackRock Institutional Trust left its MGC Diagnostics Corporation share count unchanged in Q4 2016.
  • MGC Diagnostics Corporation made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3343 holding.
  • BlackRock Institutional Trust first reported a position in MGC Diagnostics Corporation in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's MGC Diagnostics Corporation position peaked at $1.38M in Q4 2013.
  • 15 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.